Literature DB >> 2363234

Evaluation of fetal structural heart disease using color flow mapping.

Y Chiba1, T Kanzaki, H Kobayashi, M Murakami, C Yutani.   

Abstract

The technique of color flow mapping was used to diagnose 19 cases of fetal structural heart disease from a study group of 104 fetuses. Color flow mapping was 76% effective in detecting the presence of fetal structural heart disease. The colored views of a single stream in the atrioventricular canal were most impressive in cases of complete atrioventricular canal, hypoplastic left heart syndrome, mitral atresia, and tricuspid atresia. The colored views of tricuspid regurgitation were also clear in cases of endocardial fibroelastosis, pulmonary atresia with intact ventricular septum, and Ebstein's anomaly. The use of this technique resulted in the in-utero diagnoses coinciding more closely with the final diagnoses, which were made after birth. This was particularly important in those cases which required immediate management after birth.

Entities:  

Mesh:

Year:  1990        PMID: 2363234     DOI: 10.1016/0301-5629(90)90001-s

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  3 in total

1.  Imaging comparison of basic cardiac views between two- and three-dimensional ultrasound in normal fetuses in anterior spine positions.

Authors:  Po-Hui Wang; Gin-Den Chen; Long-Yau Lin
Journal:  Int J Cardiovasc Imaging       Date:  2002-02       Impact factor: 2.357

2.  Changes in the aortic and pulmonary diameters in a fetus with hypoplastic left heart syndrome.

Authors:  Katsuhiko Tada; Satoshi Yamada; Kazumasa Kumazawa; Masayo Takata; Takakimi Nakata; Hisashi Masuyama; Mikiya Nakatsuka; Takafumi Kudo; Shin-Ichi Otsuki
Journal:  J Med Ultrason (2001)       Date:  2003-06       Impact factor: 1.314

3.  Color and power Doppler combined with Fetal Intelligent Navigation Echocardiography (FINE) to evaluate the fetal heart.

Authors:  L Yeo; R Romero
Journal:  Ultrasound Obstet Gynecol       Date:  2017-08-14       Impact factor: 7.299

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.